| Oct 4 |
Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock
|
| Oct 3 |
Sector Update: Health Care Stocks Fall Late Afternoon
|
| Oct 3 |
REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
|
| Oct 3 |
Elevai Bioscience up on portfolio expansion with new filings for muscle loss treatment in obese patients
|
| Oct 3 |
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
|
| Oct 2 |
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device
|
| Sep 27 |
Altium Capital Management LP Acquires New Stake in Elevai Labs Inc
|
| Sep 24 |
Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB)
|
| Sep 23 |
Dow Gains Over 50 Points; Elevai Labs Shares Plummet
|
| Sep 23 |
Top Midday Decliners
|
